Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.
- Department of Immunotechnology
Publishing year: 2015
Publication/Series: Expert Review of Molecular Diagnostics
Document type: Journal article (comment)
Publisher: Future Drugs Ltd
Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.
- Cancer and Oncology
- ISSN: 1744-8352